Biopreservation Market by Product (Biopreservation Media, Equipment, Lab Information Management Systems), Biospecimens (Cells, Microorganisms, Organs), Application, End-User - Global Forecast 2024-2030

Biopreservation Market by Product (Biopreservation Media, Equipment, Lab Information Management Systems), Biospecimens (Cells, Microorganisms, Organs), Application, End-User - Global Forecast 2024-2030

The Biopreservation Market size was estimated at USD 2.89 billion in 2023 and expected to reach USD 3.64 billion in 2024, at a CAGR 26.98% to reach USD 15.40 billion by 2030.

Biopreservation is the process of preserving biological materials, such as cells, tissues, and organs, by stabilizing their metabolic activity at reduced temperatures. It plays a crucial role in medicine, agriculture, and biodiversity conservation. The significance of biopreservation lies in its ability to maintain the function and integrity of biological samples for extended periods, thereby facilitating research efforts, improving clinical outcomes in regenerative medicine, and conserving genetic resources. However, establishing and maintaining specialized facilities for biopreservation can be expensive, impeding their fast adoption in small-scale end-user facilities. Moreover, the need for trained personnel to handle sensitive biological materials adds a layer of complexity to managing these resources. Market players are working on introducing cost-effective biopreservation methods by advancing cryopreservation, vitrification, and hypothermic storage. Developing new cryoprotective agents (CPAs) with reduced toxicity has significantly improved the efficiency of preservation processes. Ongoing advancements aim to overcome inherent limitations and enhance the efficiency of preservation methods to ensure optimal outcomes in research, clinical applications, and biodiversity conservation efforts.

Regional Insights

In the Americas, the biopreservation industry is driven by advancements in regenerative medicine, increased investments in life sciences research, and growing awareness regarding personalized medicine. The United States and Canada observe a growing market due to its vital healthcare infrastructure and the presence of significant market players. A strong focus on research & development in the life sciences sector and increasing funding for personalized medicine initiatives primarily drive Europe's biopreservation market. The European Union (EU) has been investing significantly in projects such as the Innovative Medicines Initiative (IMI) to accelerate the development of safer and more effective treatments. Biobanking is also widely practiced across Europe, with many countries establishing national biobanks. Asia's biopreservation market is rapidly expanding due to its burgeoning pharmaceutical industry and increasing government support towards biological research activities. China, India, South Korea, and Japan are growing demands for biopreservation solutions as they invest heavily in stem cell research & therapy development.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Biopreservation Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

• Growing number of R&D activities by pharmaceutical companies
• Rising number of well-established biobanks around the world
• Rapid adoption of biopreservation in the food sector

Market Restraints

• High cost of biopreservation equipment

Market Opportunities

• Increasing automation in biopreservation, new cryoprotectants, and advanced cooling systems
• Growing investments in the field of regenerative medicine research

Market Challenges

• Availability of alternative technologies for biopreservation

Market Segmentation Analysis

• Product: Introduction of new biopreservation equipment with improved features and reliability
• End-User: Evolving utilization of the biopreservation across the gene banks

Market Disruption Analysis

• Porter’s Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biopreservation Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biopreservation Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

X-Therma Secures USD 22.4 Million in Series B Funding to Advance Biopreservation Solutions

X-Therma raised USD 22.4 million in a Series B funding round. The new capital will be utilized to further develop and enhance its innovative preservation technologies, designed to extend the viability of biological materials used in medical treatments and research. The investment underscores the growing demand for advanced biopreservation solutions that can improve the storage and transport of cells, tissues, and organs, potentially leading to significant advancements in the healthcare and biotechnology industries.

BioLife Solutions Expands Cryopreservation Line with High-Capacity IntelliRate i67C Tabletop Freezer for Cell Therapies

BioLife Solutions, Inc. launched the IntelliRate i67C an innovative tabletop freezer specifically designed to meet the growing demand for high-volume production of cell therapies. With the addition of the IntelliRate i67C, the CRF (controlled-rate freezer) product line now offers three different form factors, providing even more options for biopreservation needs. This expansion underscores BioLife Solutions' commitment to delivering cutting-edge solutions for the cell and gene therapy industry.

Upkara Secures USD 9 Million Series A for Revolutionary Biopreservation Technology Enabling Ambient Temperature Storage and Transport

Upkara, a biomedical technology company, raised USD 9 million in Series A funding. The company's patented biopreservation technology addresses the challenges posed by the cold chain and enables the storage and transportation of therapeutic and research tools at ambient temperatures. This breakthrough technology has wide-ranging applications in reagents, biobanking, and human health.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biopreservation Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biopreservation Market, highlighting leading vendors and their innovative profiles. These include Audubon Bioscience Co., Azenta, Inc., Bio-Techne Corporation, BioIVT, LLC, BioLife Solutions Inc., Charles River Laboratories International, Inc., Chart Industries, Inc., Eppendorf SE, Exact Sciences Corporation, Helmer Scientific Inc., LANXESS Corporation, Lifeline Scientific Inc., Merck KGaA, MVE Biological Solutions, OPS Diagnostics, LLC, Princeton CryoTech Inc., REPROCELL Inc., Sierra Molecular Corporation, So-Low Environmental Equipment Co., STEMCELL Technologies Inc., Taylor-Wharton, Thermo Fisher Scientific Inc., ThermoGenesis Holdings, Inc., Upkara Inc., and X-Therma Inc..

Market Segmentation & Coverage

This research report categorizes the Biopreservation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
• Biopreservation Media
• Aldehydes
• Cryoprotective Agents
• Equipment
• Consumables
• Freezers
• Nitrogen Tanks
• Refrigerators
• Lab Information Management Systems
• Biospecimens
• Cells
• Microorganisms
• Organs
• Application
• Bio-Banking
• Clinical Trials
• Drug Discovery
• Regenerative Medicine
• Therapeutics
• End-User
• Biobanks
• Gene Bank
• Hospitals

Region

• Americas
• Argentina
• Brazil
• Canada
• Mexico
• United States
• California
• Florida
• Illinois
• New York
• Ohio
• Pennsylvania
• Texas
• Asia-Pacific
• Australia
• China
• India
• Indonesia
• Japan
• Malaysia
• Philippines
• Singapore
• South Korea
• Taiwan
• Thailand
• Vietnam
• Europe, Middle East & Africa
• Denmark
• Egypt
• Finland
• France
• Germany
• Israel
• Italy
• Netherlands
• Nigeria
• Norway
• Poland
• Qatar
• Russia
• Saudi Arabia
• South Africa
• Spain
• Sweden
• Switzerland
• Turkey
• United Arab Emirates
• United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year